Qiagen (QGEN)

16.00 -0.25  -1.54%  May 31, 8:00PM Go Pro
Watch this stock
View Full Chart QGEN Price Chart

Key Stats

Market Cap 3.745B
Revenue Growth 12.17%
Profit Margin 9.65%
Earnings Yield 2.50%
Dividend Yield 0.00%
Earnings Per Share TTM 0.40
PE Ratio 39.98
Price / Sales Ratio 3.116
52 Week High 19.94
52 Week Low 12.47
Beta 0.7337
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

May 30 Conditions of Growth, Economic Analysis - Research Report on Qiagen NV and Onyx Pharm...
May 29 $QGEN making bullish move.. keep in watch list by vjtweet
May 18 Why the Street Should Love Qiagen's Earnings
May 16 Why the Street Should Love Qiagen's Earnings Fool
May 13 Will Qiagen Blow It Next Quarter?
May 08 Qiagen Beats on Both Top and Bottom Lines Fool
May 08 QIAGEN Posts 2011 Annual Report on Its Website GlobeNewswire
May 08 The Zacks Analyst Blog Highlights: Time Warner Cable, Comcast, Verizon Communication,...
May 07 Hologic's Wholly Illogical Merger Fool
May 04 Sonaecom, Telecom Italia: European Equity Market Preview
Feb 03 Stopped out $QGEN 16.07. $JCOM is still going. Moved stop to BE. by dearestleader
Feb 02 Short $QGEN 15.86. Near top of RegChannel. MACD starting to look weak. by dearestleader
Jan 31 $QGEN Reports Q4 EPS $0.31 vs $0.27 Est; Revenues $334.40M vs $322.76M Est by Benzinga
Jan 31 Earnings Tuesday (cont.) $PROV $QCRH $QGEN $RSYS $RTIX $SAIA $STX $SLGN $SPCHB $STL $TECH $TLAB $FMD $TSBK $TYC $UIS $UPS $X $UTL $UQM $VLO by ACInvestorBlog

Profile

Exchange: NASDAQGS       Sector: Services       Industry: Research Services

Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company's technologies focus on the following healthcare needs: Prevention, Profiling, Personalized Healthcare, and Point of Need. Consolidated under the Dutch holding Qiagen N.V., the company operates more than 30 subsidiaries in over 18 countries. Peer M. Schatz is the company’s Chief Executive Officer. The company was founded by Detlev H. Riesner, Metin Colpan, and Karsten Henco in 1984, and is headquartered in Venlo, Netherlands.

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Qiagen is down 18.96% over the last year vs S&P 500 Total Return up 0.88%, Myriad Genetics down 5.02%, and Gen - Probe down 1.03%.

  • QGEN Total Returns
  • ^SPXTR Total Returns
  • MYGN Total Returns
  • GPRO Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Cash Flow Statement View Statement

Get Quote for

Pro Strategies Featuring QGEN

Did Qiagen make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

QGEN Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
QGEN 16.00 -0.25 -1.54% 3.806B
QEP 26.32 +0.15 +0.57% 4.645B
QDEL 15.72 +0.18 +1.16% 513.91M
QCRH 11.97 +0.10 +0.80% 56.41M
QCOR 41.40 -0.16 -0.39% 2.643B
QCOM 57.31 -0.14 -0.24% 97.17B
QCCO 4.090 -0.00 -0.00% 70.51M
QBC 0.27 -0.03 -10.00% 23.05M
QBAK 1.94 +0.00 +0.00% 23.76M
QAI 27.30 +0.07 +0.26%
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close